Ross Muken
Stock Analyst at Evercore ISI Group
(2.46)
# 3,155
Out of 5,182 analysts
49
Total ratings
57.14%
Success rate
0.47%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Ross Muken
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CRL Charles River Laboratories International | Maintains: Outperform | $260 → $200 | $167.74 | +19.23% | 11 | Feb 19, 2026 | |
| HSIC Henry Schein | Maintains: In-Line | $78 → $70 | $78.22 | -10.51% | 10 | Aug 6, 2025 | |
| ICLR ICON Public Limited Company | Maintains: Outperform | $170 → $240 | $106.34 | +125.69% | 9 | Jul 25, 2025 | |
| A Agilent Technologies | Maintains: In-Line | $126 → $130 | $114.42 | +13.62% | 11 | Jul 2, 2024 | |
| QGEN Qiagen | Downgrades: In-Line | n/a | $37.97 | - | 2 | Jul 16, 2019 | |
| CAH Cardinal Health | Initiates: In-Line | $67 | $204.72 | -67.27% | 2 | Jan 5, 2018 | |
| ILMN Illumina | Initiates: Outperform | $250 | $125.44 | +99.30% | 2 | Jan 4, 2018 | |
| TMO Thermo Fisher Scientific | Initiates: Outperform | $220 | $466.70 | -52.86% | 1 | Jan 4, 2018 | |
| MBLY Mobileye Global | Downgrades: In-Line | n/a | $8.70 | - | 1 | Mar 13, 2017 |
Charles River Laboratories International
Feb 19, 2026
Maintains: Outperform
Price Target: $260 → $200
Current: $167.74
Upside: +19.23%
Henry Schein
Aug 6, 2025
Maintains: In-Line
Price Target: $78 → $70
Current: $78.22
Upside: -10.51%
ICON Public Limited Company
Jul 25, 2025
Maintains: Outperform
Price Target: $170 → $240
Current: $106.34
Upside: +125.69%
Agilent Technologies
Jul 2, 2024
Maintains: In-Line
Price Target: $126 → $130
Current: $114.42
Upside: +13.62%
Qiagen
Jul 16, 2019
Downgrades: In-Line
Price Target: n/a
Current: $37.97
Upside: -
Cardinal Health
Jan 5, 2018
Initiates: In-Line
Price Target: $67
Current: $204.72
Upside: -67.27%
Illumina
Jan 4, 2018
Initiates: Outperform
Price Target: $250
Current: $125.44
Upside: +99.30%
Thermo Fisher Scientific
Jan 4, 2018
Initiates: Outperform
Price Target: $220
Current: $466.70
Upside: -52.86%
Mobileye Global
Mar 13, 2017
Downgrades: In-Line
Price Target: n/a
Current: $8.70
Upside: -